Furthermore, other studies have suggested that SGLT2 appears to be uniquely expressed in well-differentiated adenocarcinoma exhibiting lepidic or papillary growth patterns, reinforcing its utility as a target for early lung malignancy [26]. This evidence concerns the gene SLC5A2 and adenocarcinoma.